Fulvestrant Injection, Solution
Product Images NDC 70771-1626

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fulvestrant (NDC 70771-1626). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pfs Mfg Label (0e88b518 F3b3 4a43 B795 F6d9dbc3b0c6 01)

The packaging label for Fulvestrant Injection, 250 mg/5 mL (50 mg/mL), an intramuscular injection. The label shows the NDC 70771-1626-2 and includes spaces for Date/Site and Administered by information. It states Rx only, made in India, and distributed by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ. Instructions note the need for 2 single-dose prefilled syringes to achieve the 500 mg dose and advise protecting the product from light.*

FDA Label Image

Carton Mfg Label (0e88b518 F3b3 4a43 B795 F6d9dbc3b0c6 02)

Packaging label for Fulvestrant Injection 250 mg/5 mL (50 mg/mL) intramuscular injection by Zydus Lifesciences Limited. The carton contains two single-dose prefilled syringes, each with 250 mg/5 mL, totaling 500 mg per carton. The label includes dosage instructions, storage information, and syringe administration guidance, along with the NDC 70771-1626-8.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.